1 Mo 5.56   |   2 Mo 5.53   |   3 Mo 5.46   |   4 Mo 5.51   |   6 Mo 5.44   |   1 Yr 5.21   |   2 Yr 4.93   |   3 Yr 4.71   |   5 Yr 4.53   |   7 Yr 4.49   |   10 Yr 4.46   |   20 Yr 4.65   |   30 Years 4.57   |  

Source: US Dept. of Treasury End of Day

Meet The Team

Mitch Henke


Chief Operating & Strategy Officer

Senior Advisor

New to Serving Public Entities, 14 Years in Finance

Professional: Mr. Henke is a principal of Government Portfolio Advisors and serves as Chief Operating and Strategy Officer as well as a Senior Advisor. He is responsible for overseeing people, processes, and operations for GPA. He has served as a Registered Investment Advisor since 2011, both in the US and Internationally, and has advised both public and private clients during his tenure. Mr. Henke specializes in cash flow analysis, and strategic asset allocation, as well as training and supervising Investment Advisors.

Mr. Henke joined Government Portfolio Advisors in 2024 after spending 14 years working for Fisher Investments. In 2014 he relocated to London to help Fisher Investments launch and manage their European Investment Advisor team, and in 2016 was promoted to Vice President responsible for leading Fisher’s entire European Private Client group. Upon the completion of his visa, Mr. Henke moved to Portland and was tasked with overseeing the design and implementation of Fisher’s International strategic growth initiatives.
Mr. Henke graduated Magna Cum Laude from Santa Clara University in 2008 with a Bachelor of Science in Finance. He was a four-year letterwinner for the Santa Clara Basketball team, was recognized as a three-time West Coast Conference All-Academic team and was the winner of the 2008 West Coast Conference Post-Graduate Scholarship. He holds his series 65 FINRA license with GPA. He has been an Investment Advisory Representative since 2011 and held a Level 4 CF30 license with the UK Financial Conduct Authority from 2014-2019.
Series 65 license from the Financial Industry Regulatory Authority (FINRA)
An Investment Advisory Representative since 2011
Scroll to Top